Analysis of Interleukin-17 mRNA Level in the Urinary Cells of Kidney Transplant Recipients with Stable Function.

Journal: Maedica
Published Date: Dec 1, 2017

Abstract

OBJECTIVES: Kidney transplantation supports patients with end-stage kidney diseases. Many factors control the allograft function in kidney transplant recipients. Interleukin-17 (IL-17) can be used as a non-invasive diagnostic biomarker of rejection. The aim of this study was to evaluate the expression of IL-17 mRNA in urinary cells of kidney transplant recipients with stable function.

Authors

  • Morteza Bagheri
    Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Ali Taghizadeh-Afshari
    Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Saeed Abkhiz
    Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Isa Abdi-Rad
    Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Mohammadreza Mohammadi-Fallah
    Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Mansour Alizadeh
    Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Saeed Sadeghzadeh
    Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals